AI reads lung cancer scans to predict best treatment

NCT ID NCT07449858

Ongoing Knowledge-focused Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Source: ClinicalTrials.gov ↗

First seen Mar 05, 2026 · Last updated May 12, 2026 · Updated 10 times

Summary

This study looks at how PET/CT scans can be used with artificial intelligence to better understand non-small cell lung cancer. Researchers will analyze scans from 500 patients to see if they can predict cancer stage, type, gene changes, and patient outcomes. The goal is to help doctors make more personalized treatment decisions without extra tests.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Guangdong Second Provincial General Hospital

Guangzhou, Guangdong, 510317, China
The First Hospital of China Medical University

Shenyang, Liaoning, 110001, China
The Second Affiliated Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, 310009, China
West China Hospital of Sichuan University

Chengdu, Sichuan, 610041, China

Conditions

Explore the condition pages connected to this study.

NON-SMALL CELL LUNG CANCER